BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25645089)

  • 21. Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.
    Cuzick J; Myers O; Lee JH; Shi Y; Gage JC; Hunt WC; Robertson M; Wheeler CM;
    JAMA Oncol; 2017 Oct; 3(10):1327-1334. PubMed ID: 28655061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of cervical intraepithelial neoplasia grade 2+ (CIN2+) using HPV DNA testing after a diagnosis of atypical squamous cell of undetermined significance (ASC-US) in Catalonia, Spain.
    Ibáñez R; Moreno-Crespi J; Sardà M; Autonell J; Fibla M; Gutiérrez C; Lloveras B; Alejo M; Català I; Alameda F; Casas M; Bosch FX; de Sanjosé S
    BMC Infect Dis; 2012 Jan; 12():25. PubMed ID: 22280073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Spinillo A; Dominoni M; Boschi AC; Cesari S; Fiandrino G; Gardella B
    Gynecol Oncol; 2020 Dec; 159(3):630-635. PubMed ID: 33041069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
    Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
    Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins.
    Sand FL; Frederiksen K; Kjaer SK
    Gynecol Oncol; 2022 Jun; 165(3):472-477. PubMed ID: 35400526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow up with HPV test and cytology as test of cure, 6 months after conization, is reliable.
    Asciutto KC; Henic E; Darlin L; Forslund O; Borgfeldt C
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1251-1257. PubMed ID: 27513888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia.
    Aydogan Kirmizi D; Baser E; Demir Caltekin M; Onat T; Sahin S; Yalvac ES
    Diagn Cytopathol; 2021 Jan; 49(1):132-139. PubMed ID: 33118711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Significance of Atypical Squamous Cells of Undetermined Significance among Patients Undergoing Cervical Conization.
    Nishimura M; Miyatake T; Nakashima A; Miyoshi A; Mimura M; Nagamatsu M; Ogita K; Yokoi T
    Asian Pac J Cancer Prev; 2015; 16(18):8145-7. PubMed ID: 26745052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long term results of follow-up after HPV self-sampling with devices Qvintip and HerSwab in women non-attending cervical screening programme.
    Bokan T; Ivanus U; Jerman T; Takac I; Arko D
    Radiol Oncol; 2021 Jan; 55(2):187-195. PubMed ID: 33764704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
    Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
    Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study.
    Bruhn LV; Hyldig N; Schledermann D
    J Low Genit Tract Dis; 2022 Oct; 26(4):287-292. PubMed ID: 36126201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix.
    Kong TW; Son JH; Chang SJ; Paek J; Lee Y; Ryu HS
    Gynecol Oncol; 2014 Dec; 135(3):468-73. PubMed ID: 25284039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical cytology and HPV test in follow-up after conisation or LLETZ.
    Ostojić DV; Vrdoljak-Mozetic D; Stemberger-Papić S; Finderle A; Eminović S
    Coll Antropol; 2010 Mar; 34(1):219-24. PubMed ID: 20432754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
    Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
    Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of prior cervical cytology and HR-HPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: a 4-year routine clinical experience after implementation of systematic training and quality control programs.
    Zhao D; Zhang L; Xie F; Peng D; Wei J; Jiang L; Zhang S; Qi D
    BMC Cancer; 2020 Aug; 20(1):810. PubMed ID: 32847541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-risk human papillomavirus E6/E7 mRNA and L1 DNA as markers of residual/recurrent cervical intraepithelial neoplasia.
    Persson M; Brismar Wendel S; Ljungblad L; Johansson B; Weiderpass E; Andersson S
    Oncol Rep; 2012 Jul; 28(1):346-52. PubMed ID: 22484610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.
    Molden T; Nygård JF; Kraus I; Karlsen F; Nygård M; Skare GB; Skomedal H; Thoresen SO; Hagmar B
    Int J Cancer; 2005 May; 114(6):973-6. PubMed ID: 15645423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia.
    Huang HJ; Tung HJ; Yang LY; Chao A; Tang YH; Chou HH; Chang WY; Wu RC; Huang CC; Lin CY; Liao MJ; Chen WC; Lin CT; Chen MY; Huang KG; Wang CJ; Chang TC; Lai CH
    Int J Cancer; 2021 Feb; 148(3):665-672. PubMed ID: 32781482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization.
    Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.